Dr Fadi Soukarieh
BSc (Hons), PhD, FHEA
School of Allied Health Professions, Nursing and Midwifery
Lecturer in Medicinal Chemistry
Full contact details
School of Allied Health Professions, Nursing and Midwifery
362 Mushroom Lane
Sheffield
S10 2TS
- Profile
-
Fadi joined the University of Sheffield in January 2025 as a Lecturer in Medicinal Chemistry to lead the development of Medicinal Chemistry teaching in the Sheffield MPharm Programme.
Fadi obtained his BSc degree in Pharmacy and Pharmaceutical Sciences from Damascus University in 2006, and his PhD in Medicinal Chemistry and Drug Design from the University of Nottingham in 2014.
Following this, Fadi has worked as a postdoctoral research fellow on various national and multinational drug discovery projects in cancer and infections.
In 2019, Fadi joined the National Biofilm Innovation Centre NBIC as an Innovation Research Fellow where he expanded his research on the management and detection of bacterial biofilm using Medicinal Chemistry and interdisciplinary approaches.
While at the University of Nottingham, Fadi became a fellow of the Higher Education Academy (FHEA) in recognition of his teaching practices for undergraduate and postgraduate students (MSc, PhD) in the School of Pharmacy and School of Life Sciences.
- Qualifications
-
BSc (Hons) Pharmacy and Pharmaceutical Sciences, Damascus University (2006)
PhD in Pharmacy, University of Nottingham (2014)
- Research interests
-
My research vision is primarily focused on the design of novel approaches to tackle bacterial infections and antimicrobial resistance (AMR) using medicinal chemistry solutions and drug discovery tools for the development of new chemotherapy candidates against bacterial pathogens with unprecedented modes of action.
I implement a highly collaborative multidisciplinary research theme integrating not only medicinal chemistry and computational chemistry but also drug delivery, surface chemistry and artificial intelligence to accelerate the discovery of antimicrobial agents against multi-drug resistant pathogens (primarily P. aeruginosa).
- Publications
-
Journal articles
- Design, Synthesis, and Evaluation of New 1H-Benzo[d]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of Medicinal Chemistry, 67(2), 1008-1023.
- Probing Interkingdom Signaling Molecules via Liquid Extraction Surface Analysis–Mass Spectrometry. Analytical Chemistry, 95(11), 5079-5086.
- Design of Quorum Sensing Inhibitor–Polymer Conjugates to Penetrate Pseudomonas aeruginosa Biofilms. ACS Macro Letters, 12(3), 314-319.
- Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa. ACS Infectious Diseases, 7(9), 2666-2685.
- Administration in fed state but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemia. European Journal of Pharmaceutics and Biopharmaceutics, 165, 106-112.
- Model-Informed Drug Discovery and Development in Pulmonary Delivery: Biopharmaceutical Pharmacometric Modeling for Formulation Evaluation of Pulmonary Suspensions. ACS Omega, 5(40), 25733-25746.
- Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR. European Journal of Medicinal Chemistry, 208, 112778-112778.
- Model-Based Drug Development in Pulmonary Delivery: Pharmacokinetic Analysis of Novel Drug Candidates for Treatment of Pseudomonas aeruginosa Lung Infection. Journal of Pharmaceutical Sciences, 108(1), 630-640.
- Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system. Journal of Controlled Release, 286, 10-19.
- Pseudomonas aeruginosa Quorum Sensing Systems as Drug Discovery Targets: Current Position and Future Perspectives. Journal of Medicinal Chemistry, 61(23), 10385-10402.
- Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisation. European Journal of Medicinal Chemistry, 124, 200-217. View this article in WRRO
- Triblock copolymer micelles enhance solubility, permeability and activity of a quorum sensing inhibitor against Pseudomonas aeruginosa biofilms. RSC Applied Polymers, 2(3), 444-455.
- Translational challenges and opportunities in biofilm science: a BRIEF for the future. npj Biofilms and Microbiomes, 8(1).
- Hit Identification of New Potent PqsR Antagonists as Inhibitors of Quorum Sensing in Planktonic and Biofilm Grown Pseudomonas aeruginosa. Frontiers in Chemistry, 8.
- In Silico and in Vitro-Guided Identification of Inhibitors of Alkylquinolone-Dependent Quorum Sensing in Pseudomonas aeruginosa. Molecules, 23(2), 257-257.
- Professional activities and memberships
-
Fellow of the Higher Education Academy (FHEA).